Department of Nephrology

Aims and Scope

The Department of Nephrology of The Gazette of Medical Sciences (The GMS) publishes peer-reviewed, open-access scholarly work addressing kidney function, renal diseases, their underlying mechanisms, and advances in diagnosis, prevention and treatment. The Department provides an international platform for nephrologists, clinicians, researchers and allied healthcare professionals to share findings that contribute to kidney health and improve patient care.

The Department welcomes original clinical and experimental research, prospective and retrospective studies, systematic and narrative reviews, case reports, case series, clinical observations, diagnostic studies, technical innovations, editorials and scholarly perspectives. Contributions may address acute kidney injury, chronic kidney disease, glomerular and tubulointerstitial disorders, inherited renal conditions, electrolyte and acid-base disturbances, and systemic diseases affecting the kidneys.

Particular interest is given to research that advances clinical decision-making, identifies meaningful biomarkers, improves dialysis and transplantation outcomes, supports patient safety and strengthens multidisciplinary renal care. The Department encourages work involving hemodialysis, peritoneal dialysis, kidney transplantation, interventional nephrology, renal pathology, kidney imaging, hypertension and the cardiovascular complications of kidney disease.

The scope also encompasses renal physiology, molecular and cellular mechanisms of kidney injury, regenerative medicine, pharmacological therapies, nutritional management, supportive care and public health approaches to kidney disease prevention. Interdisciplinary contributions involving rheumatology, endocrinology, critical care, oncology, urology, genetics and biomedical technology are welcomed.

Areas of Interest

Aging and Kidney Disease

Acute Kidney Injury: Pathogenesis, Diagnosis and Therapy

Antihypertensive Drugs

Body Fluid Volume and Composition

Clinical Nephrology

Cystic Kidney Diseases

Developmental Nephrology

Diagnostic Kidney Imaging

Dialysis and Transplantation

Endocrine Aspects of Kidney Disease

Epidemiology of Kidney Disease

Glomerular Diseases

Hemodialysis

Renal Histopathology

Inherited Disorders of Podocyte Function

Inherited Disorders of the Renal Tubule

Interventional Nephrology

Ischemic Nephropathy

Nephrolithiasis

Nephron Endowment

Obstructive Nephropathy

Pathophysiology of Uremia

Peritoneal Dialysis

Renal Anatomy

Renal Neoplasia

Renal Physiology

Renal Transplantation

Renovascular Hypertension

Tubulointerstitial Diseases

Urinary Tract Obstruction

Reflux Nephropathy

Erythropoietin Therapy

Chronic Kidney Disease

Diabetic Kidney Disease

Lupus Nephritis

Autoimmune Kidney Diseases

Electrolyte and Acid-Base Disorders

Proteinuria and Hematuria

Kidney Biopsy and Renal Pathology

Renal Biomarkers and Molecular Diagnostics

Cardiorenal Syndromes

Critical Care Nephrology

Onconephrology

Kidney Transplant Immunology

Dialysis Access and Vascular Complications

Mineral and Bone Disorders in Kidney Disease

Anemia in Chronic Kidney Disease

Renal Nutrition and Metabolic Management

Kidney Supportive and Palliative Care

Genetic and Rare Kidney Diseases

Kidney Disease Prevention and Public Health

Renal Pharmacology and Drug Safety

Regenerative and Translational Nephrology

The Department supports responsible scientific publishing, research integrity and ethical reporting. Submissions undergo editorial assessment and peer review in accordance with the journal's applicable editorial and publication policies.

Prospective

Serum Soluble Interleukin 2 Receptor Alpha vs Urinary Parameters as a monitoring tool of treatment response of Lupus Nephritis and their relation to Lupus Nephritis Class on renal biopsy

Lupus Nephritis (LN) is one of the most common and serious manifestations in SLE patients that causes significant morbidity and mortality. Current conventional biomarkers for lupus nephritis like urine sediments, proteinuria, anti-dsDNA antibodies and C3 or C4 are sometimes mislead for prediction of treatment response. Recently IL-2 R alpha has shown to be a good marker to predict treatment response of lupus nephritis.

DOI: https://www.doi.org/10.46766/thegms.nephro.20081006

View / Download Article ↗

Case Report

A positive outcome with extremely severe metabolic acidosis: A case report

This is an entrancing case report of extremely severe metabolic acidosis occurred to a 46-year-old female who was admitted to intensive care medicine, Ninewells hospital. She presented with vomiting and collapsed with significant deranged metabolic acidosis. Despite carrying very guarded prognosis on admission, fortunately she survived following effective management from multidisciplinary team in the hospital.

This case describes the metabolic acidosis in association with the mortality including the clinical presentation, management and the outcome.

DOI: https://www.doi.org/10.46766/thegms.nephro.20061906